Chronic kidney disease CKD, or chronic renal disease, is an asymptomatic, longterm condition that damages the kidneys and leads to the loss of kidney function over time NIH, 2010. As the disease progresses, the symptoms worsen, eventually leading to kidney failure NIH, 2010. The glomerular filtration rate GFR, a key measure of kidney function, is determined by the amount of creatinine in the blood, and the Kidney Disease, Improving Global Outcomes KDIGO classification system is considered the standard for GFR measurement and diagnosis of CKD.
Download FREE Sample of this Report @ https://www.24marketreports.com/report-sample/epicast-report-chronic-kidney-disease—epidemiology-forecast-to-2026-market-68
GlobalData epidemiologists provide a 10year epidemiological forecast for the total prevalent cases including both diagnosed and undiagnosed cases of CKD Stages IIV by age and sex, the total prevalent cases of CKD by stage, the diagnosed prevalent cases of CKD Stages IV, and the diagnosed prevalent cases of CKD by stage.
In the 7MM, GlobalData epidemiologists forecast the diagnosed prevalent cases of CKD, Stages IV, to increase from 25,775,828 cases in 2016 to 28,325,839 cases in 2026, at an Annual Growth Rate AGR of 0.99%. The UK will have the highest number of diagnosed cases of CKD throughout the forecast period.
Scope
The Chronic Kidney Disease EpiCast Report provides an overview of the risk factors and global trends of chronic kidney disease in the seven major markets 7MM: US, France, Germany, Italy, Spain, UK, and Japan.
This report also includes a 10year epidemiological forecast for the total prevalent cases of CKD, Stages IIV, segmented by age beginning at 20 years and ending at ages 80 years and older, by sex, and by stage. Furthermore, this report includes a forecast of the diagnosed prevalent cases of CKD, Stages IV, and the diagnosed prevalent cases of CKD by stage.
The chronic kidney disease epidemiology report is written and developed by Masters and PhDlevel epidemiologists.
The EpiCast Report is indepth, high quality, transparent and marketdriven, providing expert analysis of disease trends in the 7MM.
This report also includes a 10year epidemiological forecast for the total prevalent cases of CKD, Stages IIV, segmented by age beginning at 20 years and ending at ages 80 years and older, by sex, and by stage. Furthermore, this report includes a forecast of the diagnosed prevalent cases of CKD, Stages IV, and the diagnosed prevalent cases of CKD by stage.
The chronic kidney disease epidemiology report is written and developed by Masters and PhDlevel epidemiologists.
The EpiCast Report is indepth, high quality, transparent and marketdriven, providing expert analysis of disease trends in the 7MM.
Reasons to buy
- The Chronic Kidney Disease EpiCast report will allow you to
- Develop business strategies by understanding the trends shaping and driving the global chronic kidney disease treatment market.
- Quantify patient populations in the chronic kidney disease market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for chronic kidney disease therapeutics in each of the markets covered.
- Understand magnitude of chronic kidney disease.
Get the Complete Report & TOC @ https://www.24marketreports.com/life-sciences/epicast-report-chronic-kidney-disease—epidemiology-forecast-to-2026-market-68
No comments:
Post a Comment